Trifecta Signals

← Stocks · BDRX page

Biodexa Pharmaceuticals Plc (BDRX)

Price chart & company basics · Trifecta Signals

$2.41-$0.28 (-10.41%)Close · Thu, Nov 5, 2026

Price refreshes every trading day after the close.

In the scan since Jan 2022
BDRX closes
-98.9% 1Y · Range $2.41 – $352.00
$100$200$300 Nov ’25Jan ’26Mar ’26May ’26Jul ’26Sep ’26Nov ’26

Daily closes · through the most recent close

Price history from Jan 2018 · Signal tracking began Jan 2022

The Trifecta List

BDRX didn’t make the Trifecta List

Biodexa has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.

That’s the whole record for this stock: the chart and the basics above, and nothing to grade.

The list is the public track record: every stock that has signaled, logged, confirmed, and graded.

This page follows Biodexa Pharmaceuticals Plc, which trades under the BDRX ticker.

Across the past year, closes have spanned $2.41 to $352, and the latest close sits near the bottom of that span. The low-to-high span over the year comes to about 14506%. Price history on this page reaches back to January 2018.

At the most recent close, Thursday, November 5, the shares finished at $2.41, down 10.4% on the day. Recent trading has kept the shares between about $2.41 and $3.43 over the past week.

Download the BDRX report (PDF)Free edition — public summary · Data as of Nov 4, 2026